Coon SA, Hill LG, Hutchison RW, Arnold LM, Jarrett JB, Ottney AR, Oung AB, Painter NA, Smith MA, Stranges PM, Tran TH, McFee Winans AR, Bratberg JP. Mobilizing pharmacists to address the opioid crisis, a joint opinion of the Ambulatory Care and Adult Medicine Practice and Research Networks for the American College of Clinical Pharmacy. J Am Coll Clin Pharm. Published online ahead of print September 29, 2020.
Renfro ML, Loera LJ, Tirado CF, Hill LG. Lofexidine for acute opioid withdrawal: A clinical case series. Ment Health Clin. 2020;10(5):259-63.
Zagorski CM, Myslinski JM, Hill LG. Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspective. Int J Drug Policy. 2020;86:102939.
Hill LG, Evoy KE, Reveles KR. Reply to a letter regarding, “Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction”. J Am Pharm Assoc. 2020;60(5):e22-3.
Litten K, Hill LG, Garza A, Srinivasa M. Increasing naloxone knowledge and use through direct-to-patient education. J Pharm Technol. Published online ahead of print September 11, 2020.
Mackert M, Pounders K, Brown L, Kirtz S, Hughes Wagner J, Ring D, Hill LG, Wilcox G, Murthy D, Tierney W, Innerarity S, McGlone M, Steiker LH, DeSalvo K, Bernhardt J, Pretorius K. Development of a health communication campaign to promote the Texas prescription monitoring program. Health Mark Q. 2020;37(3):1-10.
Renfro ML, Moczygemba LR, Baumgartner J, Baumgart G, Hill LG. Type and extent of opioid-related education provided by U.S. college of pharmacy continuing education divisions. Am J Pharm Educ. Published online ahead of print June 2, 2020.
Peterson J, Barner J, Lai P, Garza A, Hinds A, Nguyen M, Hill LG, Gums T. Impact of physician-pharmacist covisits at a primary care clinic in patients with uncontrolled diabetes. J Pharm Pract. 2020;33(3):321-5.
Hill LG, Steiker LH, *Mazin L, Kinzly ML. Implementation of a collaborative model for opioid overdose prevention on campus. J Am Coll Health. 2020;68(3):223-6.
Evoy KE, Groff L, Hill LG, Godinez W, Gandhi R, Reveles KR. Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas. J Am Pharm Assoc. 2020;60:81-6.
Hill LG, Evoy KE, Reveles KR. Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction. J Am Pharm Assoc. 2019:59(6):779-82.
Hill LG, Reveles KR, Evoy KE. State-level approaches to expanding pharmacists’ authority to dispense naloxone may affect accessibility. JAMA Intern Med. 2019;179(10):1442-3.
Evoy KE, Hill LG, Groff L, Mazin L, Carlson C, Reveles KR. Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas. JAMA. 2018;320(18):1934-7.
Hill LG, Sanchez JP, Laguado SA, Lawson KA. Operation Naloxone: Overdose prevention service learning for student pharmacists. Curr Pharm Teach Learn. 2018;10(10):1348-53.
Han JK, Hill LG, Koenig ME, Das N. Naloxone counseling for harm reduction and patient engagement. Fam Med. 2017;49(9):730-3.
NPR All Things Considered | On college campuses, making overdose medication readily available
Belleville News-Democrat | Can you really overdose from fentanyl in the air? Here’s what medical experts say.
Austin American-Statesman | “We are not immune” – how the opioid crisis is hitting Central Texas
Spectrum News | Lone star crisis – the opioid epidemic
Spectrum News | Trump unveils opioid plan
Drug Topics | Four ways pharmacists are fighting opioid abuse
The Utopian | Minimizing Harm
NPR Marketplace | Overdose Prevention on College Campuses
The Daily Texan | College of Pharmacy Combats Opioid Overdose with Campus Campaign